UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015166
Receipt number R000017639
Scientific Title Target dose adjustment of busulfan in pediatric patients undergoing hematopoietic stem cell transplantation
Date of disclosure of the study information 2014/09/15
Last modified on 2024/04/02 20:13:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Target dose adjustment of busulfan in pediatric patients undergoing hematopoietic stem cell transplantation

Acronym

Target dose adjustment of busulfan in pediatric patients undergoing hematopoietic stem cell transplantation

Scientific Title

Target dose adjustment of busulfan in pediatric patients undergoing hematopoietic stem cell transplantation

Scientific Title:Acronym

Target dose adjustment of busulfan in pediatric patients undergoing hematopoietic stem cell transplantation

Region

Japan


Condition

Condition

hematological malignat disease, solid tumor, benign disease

Classification by specialty

Hematology and clinical oncology Pediatrics

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To build the safe and effective way of the administration of BU

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1 year survival after transplantation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

measurment of BU TDM

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

0 years-old <=

Age-upper limit

18 years-old >

Gender

Male and Female

Key inclusion criteria

The patient who is planed stem cell transplantation with BU as pre-conditioning

Key exclusion criteria

1 uncontroled infection
2 uncontroled mental disease
3 pregnantor possible pregnant womanan

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Seiji Kojima

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Pediatrics

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

052-744-2294

Email

kojimas@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshiyuki Takahashi

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Pediatrics

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

052-744-2294

Homepage URL


Email

ytakaha@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University

Institute

Department

Personal name



Funding Source

Organization

KAKEN

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 09 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 05 Month 07 Day

Date of IRB

2013 Year 05 Month 07 Day

Anticipated trial start date

2013 Year 05 Month 07 Day

Last follow-up date

2023 Year 09 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 09 Month 15 Day

Last modified on

2024 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017639


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name